TOKYO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. ("A.D.A.M. Innovations"), Japan's leading genomics and AI company, today announced the official ...

GeneLink Inc. Annual stock financials by MarketWatch. View the latest GNLKQ financial statements, income statements and financial ratios.

As of 6 May at 4:00:00 pm GMT-4. Market open.

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

View the basic GNLKQ option chain and compare options of GeneLink, Inc. on Yahoo Finance.

It looks like the FDA smackdown on 23andMe was only the beginning. Another personal genetics firm, GeneLink Biosciences, has been charged with false advertising by the Federal Trade Commission (FTC), ...

What Is the Average Daily Trading Volume of Genelink (GNLKQ)? The average daily trading volume for Genelink (GNLKQ) is 0. Today’s Genelink (GNLKQ) range is from 0.0001 to 0.0001. What Was the Opening ...

Both companies marketed supplements and skincare products allegedly customized to customers’ genomes that cost at least $100 a month. The FTC also took issue with lax security regarding customers’ ...

U.S. Patent number 7,211,383, entitled "KITS AND METHODS FOR ASSESSING SKIN HEALTH." was granted on May 1, 2007. This is the latest patent to be granted from a family of patent applications filed by ...

As of June 23 at 4:00:00 p.m. EDT. Market Open.

GeneLink Inc. GeneLink, Inc. is engaged in the development of genetics-based assessment products for pharmaceutical applications and DNA storage purpose. It also offers genetically customized health ...